Publications

1. Hassert M, Geerling E, Stone ET, Steffen TL, Feldman MS, Dickson AL, Class J, Richner JM, Brien JD, Pinto AK. mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2. PLoS Pathogens. 2020 Dec 16;16(12):e1009163. doi:10.1371/journal.ppat.1009163.

 

2. Wollner CJ, Richner JM. mRNA Vaccines against Flaviviruses. Vaccines (Basel). 2021 Feb 12;9(2):148. doi:10.3390/vaccines9020148.

 

3. Wollner CJ, Richner M, Hassert MA, Pinto AK, Brien JD, Richner JM. (2021) A Dengue Virus Serotype 1 mRNA-LNP Vaccine Elicits Protective Immune Responses. Journal of Virology 2021 Mar 24;JVI.02482-20. doi: 10.1128/JVI.02482-20.

 

4. Kenter AL, Richner JM. (2021) Tonsil organoids: peering down the throat of human immunity. Trends in Immunology. 2021 May;42(5):367-368. doi: 10.1016/j.it.2021.03.009.

 

5. Xiong S, Zhang L, Richner JM, Class J, Rehman J, Malik AB.(2021) Interleukin-1RA Mitigates SARS-CoV-2-Induced Inflammatory Lung Vascular Leakage and Mortality in Humanized K18-hACE-2 Mice. Arteriosclerosis Thrombosis and Vascular Biology. 2021 Sep 9 doi:10.1161/ATVBAHA.121.316925.

 

6. Dangi T, Class J, Palacio N, Richner JM*, Penaloza MacMaster P.* (2021) Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2. Cell Reports. 2021 Sep 7;36(10):109664. doi: 10.1016/j.celrep.2021.109664. * Co-corresponding authors

 

7.Dangi T, Palacio N, Sanchez S, Park M, Class J, Visvabharathy L, Ciucci T, Koralnik IJ, Richner JM*, Penaloza-MacMaster P*. (2021) Cross-protective immunity following coronavirus vaccination and coronavirus infection. Journal of Clinical Investigation. 2021 Oct 8:e151969. doi: 10.1172/JCI151969.

* Co-corresponding authors